Evidence map›Paper›PMID 42840276›Full record

ArticleFrontiers in epigenetics and epigenomics2024

Blood DNA methylation of

Richard S Lee, Alicia Santos, Henri Garrison-Desany, Anna Aulinas, Jenny L Carey, Yolanda Vives-Gilabert, Olivia H Cox, Gabriel Cuilan, Susan M Webb, Eugenia Resmini

Abstract read
In one paragraph

Article in Frontiers in epigenetics and epigenomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Richard S LeeDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Alicia SantosDepartment of Endocrinology, Hospital de la Santa Creu I Sant Pau, Research Center for Pituitary Diseases, Institut de Recerca Sant Pau (IR-Sant Pau), EndoERN, CIBERER Unit 747, ISCIII, Barcelona, Spain.
Henri Garrison-DesanyDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Anna AulinasDepartment of Endocrinology, Hospital de la Santa Creu I Sant Pau, Research Center for Pituitary Diseases, Institut de Recerca Sant Pau (IR-Sant Pau), EndoERN, CIBERER Unit 747, ISCIII, Barcelona, Spain.
Jenny L CareyDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Yolanda Vives-GilabertDepartment of Endocrinology, Hospital de la Santa Creu I Sant Pau, Research Center for Pituitary Diseases, Institut de Recerca Sant Pau (IR-Sant Pau), EndoERN, CIBERER Unit 747, ISCIII, Barcelona, Spain.
Olivia H CoxDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Gabriel CuilanDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Susan M WebbDepartment of Endocrinology, Hospital de la Santa Creu I Sant Pau, Research Center for Pituitary Diseases, Institut de Recerca Sant Pau (IR-Sant Pau), EndoERN, CIBERER Unit 747, ISCIII, Barcelona, Spain.
Eugenia ResminiDepartment of Endocrinology, Hospital de la Santa Creu I Sant Pau, Research Center for Pituitary Diseases, Institut de Recerca Sant Pau (IR-Sant Pau), EndoERN, CIBERER Unit 747, ISCIII, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The impact of chronic exposure to stress or glucocorticoids on psychiatric symptoms has been exemplified by cases of iatrogenic or endogenous hypercortisolism such as Cushing's syndrome (CS). The amygdala plays an important role in mediating both stress and affective responses, and one of the key factors that link stress response and psychiatric symptoms is the corticotropin-releasing factor (CRF). Epigenetic changes, especially those occurring on CpG dinucleotides in DNA of glucocorticoid target genes in blood, have been previously implicated as potential predictors of glucocorticoid-related events in the central nervous system (CNS). In this study, we examined amygdala volume and mood symptoms in CS patients and aimed at evaluating whether these parameters were associated with blood DNA methylation of Methods: In this cross-sectional study, 32 CS patients and 32 healthy controls matched for age, sex, and years of education underwent an MRI scan, a Beck Depression Inventory-II, and a State-Trait Anxiety Inventory. Genomic DNA extracted from total leukocytes were used for DNA methylation analysis of several CpG dinucleotides at the Results: Significant associations between Conclusion: These results demonstrate that methylation levels of the

Indexed as

amygdalacorticotropin-releasing factorCushing’s syndromeDNA methylationhypercortisolism

Identifiers

PMID42840276
PMCPMC13639298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.